Wenbin Zeng - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Wenbin Zeng

Showing results (141-150 of 143) with videos related to

Pageof 15

Sort By:

You have reached the last page of results.This site can display upto 143 results.

Journal of Hematology & Oncology|September 26, 2021

Kynurenine derivative 3-HAA is an agonist ligand for transcription factor YY1Zhaopeng Shi, Guifang Gan, Xiang Xu, et al.

Frontiers in Oncology|September 7, 2021

A Real-World Observation of Eltrombopag and Recombinant Human Thrombopoietin (rhTPO) in Lymphoma Patients With Chemotherapy Induced ThrombocytopeniaQiuhua Zhu, Shimei Yang, Wenbin Zeng, et al.

Frontiers in Immunology|April 18, 2022

IL-6 and IL-10 Are Associated With Gram-Negative and Gram-Positive Bacteria Infection in LymphomaQiuhua Zhu, Huan Li, Shanshan Zheng, et al.

Pageof 15

Search research articles

Showing results (141-150 of 143) with videos related to

Sort By:

Pageof 15

You have reached the last page of results.This site can display upto 143 results.

Journal of Hematology & Oncology|September 26, 2021

Kynurenine derivative 3-HAA is an agonist ligand for transcription factor YY1Zhaopeng Shi, Guifang Gan, Xiang Xu, et al.

Frontiers in Oncology|September 7, 2021

A Real-World Observation of Eltrombopag and Recombinant Human Thrombopoietin (rhTPO) in Lymphoma Patients With Chemotherapy Induced ThrombocytopeniaQiuhua Zhu, Shimei Yang, Wenbin Zeng, et al.

Frontiers in Immunology|April 18, 2022

IL-6 and IL-10 Are Associated With Gram-Negative and Gram-Positive Bacteria Infection in LymphomaQiuhua Zhu, Huan Li, Shanshan Zheng, et al.

Pageof 15